NCT01438723View on ClinicalTrials.gov

The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Cardiovascular DiseaseIschemic Heart Disease
Interventions
DRUG

Metformin

prior to CAGB surgery 3 day treatment with metformin 500 mg three times a day

DRUG

Placebo

prior to CABG surgery 3 day treatment with placebo capsules three times a day

Trial Locations (1)

Unknown

RUNMC, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01438723 - The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial | Biotech Hunter | Biotech Hunter